[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons]

Haematologica. 1990 Jul-Aug:75 Suppl 4:20-7.

[Article in Italian]

Authors

M Cazzola¹, P Pedrazzoli, G Bergamaschi, C Buonanno, A Cuomo, R D'Uva, L Ponchio, V Rosti, E Zappone, E Ascari

Affiliation

¹ Dipartimento di Medicina Interna e Terapia Medica, Università, Pavia.

PMID: 2127411

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't
Review

MeSH terms

Cell Division / drug effects
Chromosome Aberrations
Clone Cells / pathology
Genetic Markers
Hematopoietic Stem Cells / drug effects
Hematopoietic Stem Cells / pathology
Humans
Interferon Type I / pharmacology
Interferon Type I / therapeutic use*
Interferon-gamma / pharmacology
Interferon-gamma / therapeutic use*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Neoplastic Stem Cells / drug effects
Neoplastic Stem Cells / pathology
Oncogenes
Recombinant Proteins

Substances

Genetic Markers
Interferon Type I
Recombinant Proteins
Interferon-gamma